1. de Lange, Katrina M, Moutsianas, Loukas, Lee, James C, Anderson, Carl A, Barrett, Jeffrey C. 2017. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. In Nature genetics, 49, 256-261. doi:10.1038/ng.3760. https://pubmed.ncbi.nlm.nih.gov/28067908/
2. Wu, Dan, Zhang, Pinglu, Ma, Ji, Chen, Meifen, Xu, Hongtao. 2019. Serum biomarker panels for the diagnosis of gastric cancer. In Cancer medicine, 8, 1576-1583. doi:10.1002/cam4.2055. https://pubmed.ncbi.nlm.nih.gov/30873760/
3. Teng, Lisha, Shen, Lingling, Zhao, Wenjun, Chen, Jianghua, Jiang, Hong. 2022. SLAMF8 Participates in Acute Renal Transplant Rejection via TLR4 Pathway on Pro-Inflammatory Macrophages. In Frontiers in immunology, 13, 846695. doi:10.3389/fimmu.2022.846695. https://pubmed.ncbi.nlm.nih.gov/35432371/
4. Zheng, Yuli, Wang, Liudi, Zhao, Yan, Qi, Yao, Qi, Le. 2023. Upregulation of SLAMF8 aggravates ischemia/reperfusion-induced ferroptosis and injury in cardiomyocyte. In International journal of cardiology, 399, 131688. doi:10.1016/j.ijcard.2023.131688. https://pubmed.ncbi.nlm.nih.gov/38158136/
5. Wang, Yibo, Hang, Kai, Wu, Xiaoyong, Pan, Zhijun, Zou, Xuenong. 2024. SLAMF8 regulates osteogenesis and adipogenesis of bone marrow mesenchymal stem cells via S100A6/Wnt/β-catenin signaling pathway. In Stem cell research & therapy, 15, 349. doi:10.1186/s13287-024-03964-1. https://pubmed.ncbi.nlm.nih.gov/39380096/
6. Chen, Nachun, Fan, Baoying, He, Zhiyong, Yu, Xinping, Wang, Jinjun. 2022. Identification of HBEGF+ fibroblasts in the remission of rheumatoid arthritis by integrating single-cell RNA sequencing datasets and bulk RNA sequencing datasets. In Arthritis research & therapy, 24, 215. doi:10.1186/s13075-022-02902-x. https://pubmed.ncbi.nlm.nih.gov/36068607/
7. Qin, Wenyi, Rong, Xiaofeng, Yu, Chao, Yang, Juan, Zhou, Guoqing. 2022. Knockout of SLAMF8 attenuates collagen-induced rheumatoid arthritis in mice through inhibiting TLR4/NF-κB signaling pathway. In International immunopharmacology, 107, 108644. doi:10.1016/j.intimp.2022.108644. https://pubmed.ncbi.nlm.nih.gov/35259711/
8. Li, Guangyao, Li, Qijiao, Ping, Miaomiao, Guo, Jizheng, Cheng, Ya. 2024. SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer. In Aging, 16, 8944-8964. doi:10.18632/aging.205850. https://pubmed.ncbi.nlm.nih.gov/38787377/
9. Zhang, Yaping, Zhang, Qun, Han, Xingzhi, Shi, Xiao, Qian, Xiaoping. 2023. SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer. In Translational oncology, 31, 101654. doi:10.1016/j.tranon.2023.101654. https://pubmed.ncbi.nlm.nih.gov/36931016/
10. Zhang, Qun, Cheng, Lei, Qin, Yanmei, Liu, Chenchen, Qian, Xiaoping. 2021. SLAMF8 expression predicts the efficacy of anti-PD1 immunotherapy in gastrointestinal cancers. In Clinical & translational immunology, 10, e1347. doi:10.1002/cti2.1347. https://pubmed.ncbi.nlm.nih.gov/34729183/